The interface of perinatal HIV prevention, antiretroviral drug resistance, and antiretroviral treatment: what do we really know?
Mary Glenn
MG
Fowler
Lynne
L
Mofenson
Michelle
M
McConnell
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D024882:Drug Resistance, Viral; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control / Q000635:transmission; D015497:HIV-1 / Q000254:growth & development*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000821:virology
D019380:Anti-HIV Agents